Monday September 14, 2026
Section

Globe Newswire

Etienna Bio Completes FDA INTERACT Meeting for ETB-001
Press Release

Etienna Bio Completes FDA INTERACT Meeting for ETB-001

LEAWOOD, Kan., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Etienna Bio, Inc. today announced that it completed an INTERACT

Read Full Story